What Do BI-RADS 3 and 4 Mean for a Suspected Fibroadenoma?

When your breast imaging report labels a suspected fibroadenoma (a common, benign breast lump) as BI-RADS 3 or BI-RADS 4, it is communicating the radiologist’s assessment category based on how the lump looks on imaging. This is an imaging recommendation, not a final diagnosis or a disease stage. A BI-RADS 3 assessment means the finding is “probably benign,” with a population-level estimated risk of cancer of 2% or less ^[1][2]. Instead of an immediate biopsy, this category usually leads to short-interval follow-up imaging to monitor the lump for stability ^[1][3]. A BI-RADS 4 assessment means the finding is “suspicious” for malignancy (an estimated risk greater than 2% but less than 95%) and is concerning enough to warrant a tissue biopsy ^[1][2]. It is important to know that a BI-RADS 4 category does not mean you definitely have cancer, only that an image-guided biopsy is the standard way to find out exactly what the lump is.

Understanding the BI-RADS Categories

The Breast Imaging Reporting and Data System (BI-RADS) is a standardized way for radiologists to describe breast imaging results and recommend follow-up care.

BI-RADS 3: Probably Benign

A suspected fibroadenoma is typically given a BI-RADS 3 category after a complete diagnostic assessment when it has a classic benign appearance on an ultrasound—such as an oval or round shape, clear and distinct edges (circumscribed margins), and lying parallel to the skin ^[1][4].

Because the estimated risk of malignancy for this specific imaging finding is 2% or less, the standard recommendation is short-interval imaging ^[1]. This means returning for another scan sooner than your normal yearly screening. While a common schedule is 6, 12, and 24 months from the baseline scan, the exact timing depends on your age, imaging method, and clinical history ^[3]. A large screening database study showed that completing this closely monitored follow-up catches very rare cases of cancer early, avoiding biopsy when the imaging remains appropriately classified as probably benign ^[3].

BI-RADS 4: Suspicious Abnormality

A BI-RADS 4 category is given when a lump lacks the classic benign features of a fibroadenoma or has traits that require closer investigation under a microscope. Because this category covers a very wide range of estimated risk, radiologists often break it down into subcategories to communicate the specific level of concern ^[5][2]:

• BI-RADS 4A: Low suspicion for malignancy (greater than 2% to 10% risk)
• BI-RADS 4B: Moderate suspicion for malignancy (greater than 10% to 50% risk)
• BI-RADS 4C: High suspicion for malignancy (greater than 50% to less than 95% risk)

Regardless of the subcategory, a BI-RADS 4 finding typically comes with a recommendation for an image-guided core-needle biopsy ^[5]. During this procedure, the area is numbed with local anesthetic, and a radiologist uses a needle to take small tissue samples (often placing a tiny marker clip) to confirm the diagnosis.

Why Would a Fibroadenoma Change from BI-RADS 3 to BI-RADS 4?

If you are undergoing short-interval imaging for a BI-RADS 3 lump, the radiologist is carefully looking for stability. If the lump changes between visits, they may escalate the assessment to BI-RADS 4 and recommend a biopsy. An escalation to BI-RADS 4 does not prove a benign fibroadenoma has turned into cancer. Rather, an imaging finding initially thought to be a fibroadenoma can occasionally represent another type of lesion, and new changes simply mean the lump needs a tissue diagnosis ^[6].

Reasons for reassessment and escalation include:

• Changes in Shape or Margins: If an initially oval, smooth lump develops irregular shapes, fuzzy borders, or a nonparallel orientation (taller than it is wide), it will be upgraded ^[7][8].
• Interval Growth: Some fibroadenomas enlarge benignly due to hormonal changes. However, substantial or rapid enlargement may prompt your clinician to recommend a biopsy ^[8]. Lumps initially presumed to be fibroadenomas are sometimes biopsied to rule out a phyllodes tumor (a rare breast tumor that can mimic a fibroadenoma and may be benign, borderline, or malignant) ^[9][10].
• New Clinical Findings: If your doctor discovers new symptoms that don’t match the benign imaging—such as a new palpable mass, persistent skin or nipple changes, or unexplained armpit swelling—the clinical picture may prompt a biopsy ^[11][12]. You should not wait for your next scheduled scan if you notice these new changes.
• Discordant Imaging Features: Sometimes, an additional imaging technique contradicts the otherwise benign shape of the lump. For instance, if an ultrasound technique called elastography measures the lump as unusually stiff, the radiologist considers this discordant feature alongside the rest of your imaging and may escalate the category ^[13].
• Imaging-Pathology Mismatch: If you already had a core biopsy that showed a benign fibroadenoma, but your lump later develops highly suspicious features on imaging, this creates an “imaging-pathology mismatch.” Because the benign pathology result does not adequately explain the concerning imaging appearance, your care team may escalate the assessment to recommend another biopsy or surgical removal ^[13][9].

What Happens Next?

• If BI-RADS 3: Schedule and attend the exact follow-up imaging timeline recommended in your report. Do not skip these appointments.
• If BI-RADS 4: Contact your clinician or breast clinic promptly to arrange the recommended core-needle biopsy. Do not try to self-diagnose based on the 4A/4B/4C subcategory.

Once a biopsy provides a definitive benign diagnosis (like a confirmed fibroadenoma) that aligns with the imaging, many lumps require no further treatment. However, your doctor may discuss removal if the lump is very large, symptomatic, or continues to grow ^[9].